Multicenter retrospective analysis of cardiovascular risk factors affecting long-term outcome of de novo cardiac transplant recipients

被引:62
作者
Kobashigawa, Jon A.
Starling, Randall C.
Mehra, Mandeep R.
Kormos, Robert L.
Bhat, Geetha
Barr, Mark L.
Sigouin, Chris S.
Kolesar, June
Fitzsimmons, William
机构
[1] Univ Calif Los Angeles, Heart Transplant Program, Los Angeles, CA 90095 USA
[2] Cleveland Clin Fdn, Cleveland, OH 44195 USA
[3] Univ Maryland, Baltimore, MD 21201 USA
[4] Univ Pittsburgh, Pittsburgh, PA USA
[5] Univ So Calif, Los Angeles, CA USA
[6] Astellas Pharma Inc, Tokyo, Japan
关键词
D O I
10.1016/j.healun.2006.05.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Previous risk factor studies in cardiac transplant patients have analyzed pre-transplant risk factors as they relate to outcomes. This study is the first in-depth multicenter assessment of ongoing post-transplant risk factors in heart transplant patients and their impact on 5-year outcomes. Methods: We reviewed 280 heart transplant patients who survived > 1 year for the impact of post-transplant risk factors (hyperhpidemia, hypertension, diabetes, body mass index [BMI] and renal dysfunction: 8 to 18 possible measurements over 5 years) on outcomes, including death, cardiac allograft vasculopathy (CAV) and non-fatal major adverse cardiac events (NF-MACE). Results: Upon multivariate Cox regression analysis, significant findings were high total-cholesterol for NF-MACE (relative risk [RR] = 4.34, confidence interval [CI] 1.35 to 13.98, p = 0.01), presence of diabetes for NF-MACE (RR = 3.96, ci 1.24 to 12.65, P = 0.02) and high serum creatinine for graft death (RR = 1.59, Cl 1.35 to 1.87,p < 0.001). No covariates were found to be significant for CAV. Other significant risk factors by univariate Cox regression models with time-dependent covariates included BMI >= 33 for graft death. Conclusions: Post-transplant risk factors of hypercholesterolemia and diabetes are associated with NF-MACE, whereas high serum creatinine and BMI 33 are associated with graft death. Risk factor modification, including direct therapy to minimize risk factors, should be considered.
引用
收藏
页码:1063 / 1069
页数:7
相关论文
共 32 条
[1]   High-dose angiotensin-converting enzyme inhibition restores body fluid homeostasis in heart-transplant recipients [J].
Braith, RW ;
Mills, RM ;
Wilcox, CS ;
Davis, GL ;
Hill, JA ;
Wood, CE .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (03) :426-432
[2]   Hypotension, acidosis, and vasodilatation syndrome post-heart transplant: Prognostic variables and outcomes [J].
Chemmalakuzhy, J ;
Costanzo, MR ;
Meyer, P ;
Piccione, W ;
Kao, W ;
Winkel, E ;
Saltzberg, M ;
Heroux, A ;
Parrillo, J .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2001, 20 (10) :1075-1083
[3]   The impact of diabetes mellitus at the time of heart transplantation on long-term survival [J].
Czerny, M ;
Sahin, V ;
Fasching, P ;
Zuckermann, A ;
Zimpfer, D ;
Kilo, J ;
Wolner, E ;
Grimm, M .
DIABETOLOGIA, 2002, 45 (11) :1498-1508
[4]  
Day JD, 1995, J HEART LUNG TRANSPL, V14, pS142
[5]   ANTIENDOTHELIAL ANTIBODIES AND CORONARY-ARTERY DISEASE AFTER CARDIAC TRANSPLANTATION [J].
DUNN, MJ ;
CRISP, SJ ;
ROSE, ML ;
TAYLOR, PM ;
YACOUB, MH .
LANCET, 1992, 339 (8809) :1566-1570
[6]   CARDIAC ALLOGRAFT VASCULOPATHY ASSESSED BY INTRAVASCULAR ULTRASONOGRAPHY AND NONIMMUNOLOGICAL RISK-FACTORS [J].
ESCOBAR, A ;
VENTURA, HO ;
STAPLETON, DD ;
MEHRA, MR ;
RAMEE, SR ;
COLLINS, TJ ;
JAIN, SP ;
SMART, FW ;
WHITE, CJ .
AMERICAN JOURNAL OF CARDIOLOGY, 1994, 74 (10) :1042-1046
[7]   Risk factors for chronic renal dysfunction in cardiac allograft recipients [J].
Esposito, C ;
Semeraro, L ;
Bellotti, N ;
Fasoli, G ;
Fornoni, A ;
Rampino, T ;
Klersy, C ;
Campana, C ;
Gavazzi, A ;
Viganò, M ;
Dal Canton, A .
NEPHRON, 2000, 84 (01) :21-28
[8]   Are preoperative obesity and cachexia risk factors for post heart transplant morbidity and mortality: A multi-institutional study of preoperative weight-height indices [J].
Grady, KL ;
White-Williams, C ;
Naftel, D ;
Costanzo, MR ;
Pitts, D ;
Rayburn, B ;
VanBakel, A ;
Jaski, B ;
Bourge, R ;
Kirklin, J .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 1999, 18 (08) :750-763
[9]   Donor hepatitis-C seropositivity is an independent risk factor for the development of accelerated coronary vasculopathy and predicts outcome after cardiac transplantation [J].
Haji, SA ;
Starling, RC ;
Avery, RK ;
Mawhorter, S ;
Tuzcu, EM ;
Schoenhagen, P ;
Cook, DJ ;
Ratliff, NB ;
McCarthy, PM ;
Young, JB ;
Yamani, MH .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2004, 23 (03) :277-283
[10]   The registry of the International Society for Heart and Lung Transplantation: Nineteenth official report-2002 [J].
Hertz, MI ;
Taylor, DO ;
Trulock, EP ;
Boucek, MM ;
Mohacsi, PJ ;
Edwards, LB ;
Keck, BM .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2002, 21 (09) :950-970